NES and acute myeloid leukemia: It is worth noting that the presence of high numbers of primitive Nestin+ MSPCs and CFU-Fs in the BM of AML patients at baseline predicted early relapse after treatment, whereas large numbers of more mature MSPCs or osteoblastic cells were significantly associated with more delayed late relapse [182].